1. Home
  2. AEVA vs PHAT Comparison

AEVA vs PHAT Comparison

Compare AEVA & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEVA
  • PHAT
  • Stock Information
  • Founded
  • AEVA 2019
  • PHAT 2018
  • Country
  • AEVA United States
  • PHAT United States
  • Employees
  • AEVA N/A
  • PHAT N/A
  • Industry
  • AEVA Auto Parts:O.E.M.
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEVA Consumer Discretionary
  • PHAT Health Care
  • Exchange
  • AEVA Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • AEVA 1.0B
  • PHAT 835.7M
  • IPO Year
  • AEVA N/A
  • PHAT 2019
  • Fundamental
  • Price
  • AEVA $17.09
  • PHAT $11.61
  • Analyst Decision
  • AEVA Strong Buy
  • PHAT Strong Buy
  • Analyst Count
  • AEVA 5
  • PHAT 5
  • Target Price
  • AEVA $20.80
  • PHAT $16.40
  • AVG Volume (30 Days)
  • AEVA 2.4M
  • PHAT 1.2M
  • Earning Date
  • AEVA 11-05-2025
  • PHAT 11-06-2025
  • Dividend Yield
  • AEVA N/A
  • PHAT N/A
  • EPS Growth
  • AEVA N/A
  • PHAT N/A
  • EPS
  • AEVA N/A
  • PHAT N/A
  • Revenue
  • AEVA $13,825,000.00
  • PHAT $114,039,000.00
  • Revenue This Year
  • AEVA $110.19
  • PHAT $213.11
  • Revenue Next Year
  • AEVA $96.22
  • PHAT $91.84
  • P/E Ratio
  • AEVA N/A
  • PHAT N/A
  • Revenue Growth
  • AEVA 111.39
  • PHAT 1049.82
  • 52 Week Low
  • AEVA $2.52
  • PHAT $2.21
  • 52 Week High
  • AEVA $38.80
  • PHAT $19.50
  • Technical
  • Relative Strength Index (RSI)
  • AEVA 55.69
  • PHAT 50.17
  • Support Level
  • AEVA $14.10
  • PHAT $11.74
  • Resistance Level
  • AEVA $18.80
  • PHAT $12.49
  • Average True Range (ATR)
  • AEVA 1.56
  • PHAT 0.80
  • MACD
  • AEVA 0.08
  • PHAT -0.04
  • Stochastic Oscillator
  • AEVA 59.75
  • PHAT 35.24

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: